Fatigue affects health status and predicts mortality among subjects with COPD: Report from the population-based OLIN COPD study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 2, 2015, Pages 199-206

  Stridsman, Caroline ^a,b   Skär, Lisa ^a   Hedman, Linnea ^b   Rnmark, Eva ^c   Lindberg, Anne ^c  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^b Norrbotten County Council   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Chronic obstructive pulmonary disease; Death; Epidemiologic studies; Quality of life; Symptom assessment

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; HEALTH STATUS; HUMAN; LUNG FUNCTION TEST; MALE; MENTAL HEALTH; MORTALITY; PRIORITY JOURNAL; SHORT FORM 36; SMOKING HABIT; STRUCTURED INTERVIEW; CASE CONTROL STUDY; COHORT ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVEYS AND QUESTIONNAIRES;

EID: 84928942572     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.922176     Document Type: Article

References (41)

1. Th e Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2014 [Cited 1 Mars 2014]: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www. goldcopd.org.
2. Blinderman C, Homel P, Billings A, Tennsteds S, Portenoy R. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manag 2009;38:115-123.
3. Th eander K, Unosson M. Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004;45:172-177.
4. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med 2008;102:399-406.
5. Bridevaux P, Gerbase MW, Probst NM, Schindler C, Gaspoz J, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modifi ed GOLD stage 1 COPD. Th orax 2008;63:768-774.
6. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2010;1:57-66.
7. Stridsman C, Muellerova H, Skär L, Lindberg A. Fatigue in COPD and the impact of respiratory symptoms and heart disease-A population-based study. COPD 2013;10:125-132.
8. Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest 1998;114:958.
9. Peters JB, Heidra YF, Dandey L, et al. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns 2011;85:281-285.
10. Th eander K, Jakobsson P, Torstensson O, Unosson M. Severity of fatigue is related to functional limitation and health in patients with chronic obstructive pulmonary disease. Int J Nurs Pract 2008;14:455-462.
11. Lindberg A, Larsson LG, Muellerova H, Rönmark E, Lundbäck B. Up-to-date on mortality in COPD-report from the OLIN COPD study. BMC Pulm Med 2012;12:1.
12. Lundbäck B, Eriksson B, Lindberg A, et al. A 20-year follow-up of a population study-based COPD cohort-report from the Obstructive Lung Disease in Northern Sweden studies. COPD 2009;6:263-271.
13. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28:1245-1257.
14. de Miguel-Díez J, Carrasco-Garrido P, Rejas-Gutierrez J, et al. Th e infl uence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord 2010;10:8.
15. Esteban C, Quintana JM, Aburto M, et al. Predictors of mortality in patients with stable COPD. J Gen Intern Med 2008;23:1829-1834.
16. Domingo Salvany A, Lamarca R, Ferrer M, et al. Healthrelated quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-685.
17. Sundh J, Janson C, Lisspers K, Montgomery S, Stallberg B. Clinical COPD questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis 2012;7:833-842.
18. Lindberg A, Bjerg A, Ronmark E, Larsson L, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden studies. Respir Med 2006;100:264-272.
19. Miravitlles M, Soriano JB, Garcia-Rio F. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Th orax 2009;64:863-868.
20. Lindberg A, Lundbäck B. Th e Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease study: Design, the fi rst year, participation and mortality. Clin Respir J 2008;2:64-71.
21. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-586.
22. Cella D. Manual of the Functional Assessment of Chronic Illness Th erapy (FACIT) Measurement System. Evanston, IL: Center on Outcomes, Research and Education (Core), Evanston Northwestern Healthcare and Northwestern University, 1997.
23. Cella D, Lai J, Chang C, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002;94:528-538.
24. Baghai-Ravary R, Quint J, Goldring J, Hurst J, Donaldson G, Wedzicha J. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009;103:216-223.
25. Al-shair K, Muellerova H, Yorke J, et al. Examining fatigue in COPD: Development, validity and reliability of a modifi ed version of FACIT-F scale. Health Qual Life Outcomes 2012;10:100.
26. Sullivan M, Karlsson J, Ware JE. Th e Swedish SF-36 health survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349-1358.
27. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston: New England Medical Center, 1993.
28. ATS. American thoracic society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
29. Berglund E, Birath G, Grimsby G, et al. Spirometric studies in normal subjects. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963;173:185-192.
30. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999;116:1632-1637.
31. Kelly JL, Elkin SL, Fluxman J, Polkey MI, Soljak MA, Hopkinson NS. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care. COPD 2013;10:40-54.
32. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005;3:56.
33. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005;32:811-819.
34. Hardy SE, Studenski SA. Fatigue predicts mortality in older adults. J Am Geriatr Soc 2008;56:1910-1914.
35. Sundh J, Janson C, Lisspers K, Stallberg B, Montgomery S. Th e dyspnoea, obstruction, smoking, exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J 2012;21:295-301.
36. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and fi rst validation of the COPD assessment test. Eur Respir J 2009;34:648-654.
37. Sin DD, Man SF. Systemic infl ammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 2007;85:141-147.
38. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic infl ammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011;12:3.
39. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995;107:1585-1589.
40. Bakke PS, Rönmark E, Eagan T, Pistelli F, Annesie-Maesono I, Maly M, et al. Recommendations for epidemiological studies on COPD. Eur Respir J 2011;38:1261-1277.
41. Boutou AK, Shrikrishna D, Tanner RJ, Smith C, Kelly JL, Ward SP, et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013;42:616-625.